StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.21+0.14 (+0.56%)

Close on Nov 17, 2026Market cap $666.15MP/E –Yield –

Fulgent Genetics cash

Cash and short-term investments held at the end of each period.

Fulgent Genetics's cash was $257.03M at Jun 30, 2026. For fiscal 2025 it was $336.08M, up 30.1% from the year before. Over ten years it grew 92.2% a year on average. The highest annual figure on record is $336.08M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$336.08M+30.1%
FY2024Dec 31, 2024$258.24M+164.9%
FY2023Dec 31, 2023$97.47M+22.6%
FY2022Dec 31, 2022$79.51M-51.8%
FY2021Dec 31, 2021$164.89M-44.9%
FY2020Dec 31, 2020$299.37M+959.0%
FY2019Dec 31, 2019$28.27M-8.9%
FY2018Dec 31, 2018$31.03M+17.2%
FY2017Dec 31, 2017$26.48M+235.4%
FY2016Dec 31, 2016$7.90M+1514.9%
FY2015Dec 31, 2015$489.00K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$257.03M+192.5%
Q1 FY2026Mar 31, 2026$276.30M+310.7%
Q4 FY2025Dec 31, 2025$336.08M+30.1%
Q3 FY2025Sep 30, 2025$117.64M+102.7%
Q2 FY2025Jun 30, 2025$87.88M+35.0%
Q1 FY2025Mar 31, 2025$67.28M+23.1%
Q4 FY2024Dec 31, 2024$258.24M+164.9%
Q3 FY2024Sep 30, 2024$58.04M-31.0%
Q2 FY2024Jun 30, 2024$65.11M+11.6%
Q1 FY2024Mar 31, 2024$54.68M-17.4%
Q4 FY2023Dec 31, 2023$97.47M+22.6%
Q3 FY2023Sep 30, 2023$84.08M-50.2%
Q2 FY2023Jun 30, 2023$58.35M-58.0%
Q1 FY2023Mar 31, 2023$66.17M-81.3%
Q4 FY2022Dec 31, 2022$79.51M-51.8%
Q3 FY2022Sep 30, 2022$168.77M-21.5%
Q2 FY2022Jun 30, 2022$138.78M+38.1%
Q1 FY2022Mar 31, 2022$353.07M+133.1%
Q4 FY2021Dec 31, 2021$164.89M-44.9%
Q3 FY2021Sep 30, 2021$214.88M+186.8%
Q2 FY2021Jun 30, 2021$100.46M+379.3%
Q1 FY2021Mar 31, 2021$151.46M+454.2%
Q4 FY2020Dec 31, 2020$299.37M+959.0%
Q3 FY2020Sep 30, 2020$74.94M+133.3%
Q2 FY2020Jun 30, 2020$20.96M-22.3%
Q1 FY2020Mar 31, 2020$27.33M-7.1%
Q4 FY2019Dec 31, 2019$28.27M-8.9%
Q3 FY2019Sep 30, 2019$32.12M-1.5%
Q2 FY2019Jun 30, 2019$26.99M+638.5%
Q1 FY2019Mar 31, 2019$29.43M+458.0%
Q4 FY2018Dec 31, 2018$31.03M+17.2%
Q3 FY2018Sep 30, 2018$32.60M+244.0%
Q2 FY2018Jun 30, 2018$3.65M-68.2%
Q1 FY2018Mar 31, 2018$5.27M-21.7%
Q4 FY2017Dec 31, 2017$26.48M+235.4%
Q3 FY2017Sep 30, 2017$9.48M+15.5%
Q2 FY2017Jun 30, 2017$11.47M–
Q1 FY2017Mar 31, 2017$6.73M–
Q4 FY2016Dec 31, 2016$7.90M–
Q3 FY2016Sep 30, 2016$8.21M–

More Fulgent Genetics figures

See a number that looks wrong?